Pops! Diabetes Care announced today the commercial launch of its blood glucose monitoring system.
The Minneapolis-based company’s device won FDA clearance in December last year.
Get the full story at our sister site, Drug Delivery Business News.
Home » Pops! Diabetes Care launches blood glucose monitoring system
In case you missed it
- Avanos launches third restructuring phase
- J&J’s Ethicon wins clearance for devices to deliver Grifols surgical sealant
- Ajax Health takes second fund to $100m
- Philips wins PMAs for OTC automated external defibs
- FDA: More data needed on paclitaxel devices
- Survey: Few adults know signs of heart failure
- FDA clears Life Spine’s surgical spacer system
- Ra Medical launches large registry trial for peripheral laser atherectomy device
- Ginkgo puts $80 million into Synlogic
- Global medical device regulatory trends
- iCad closes $10m offering
- Tekni-Plex buys three healthcare packaging plants
- Bain raises $900m for new life science fund
- Cook Medical recalls peripheral catheters on burst balloon risk
- Axonics wins FDA nod for MR-safe neurostim device in trial
- Gel-e gains breakthrough device nod for internal bleeding control device
- Zoll acquires TherOx
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.